Uncategorized
Uncategorized
GLP-1 drugs like Wegovy are all the rage—but people are quitting them too fast to achieve meaningful weight loss, finds 170,000-patient study
Sales of antiobesity drugs hit $1.1 billion in the second quarter of 2023.
Uncategorized
Bitcoin hits $100,000 as Trump era hopes grow
Cryptocurrency has climbed more than 40% since US election on bets president-elect will bring in pro-crypto regulation
Uncategorized
Cities are still trying to figure things out post-pandemic—and that’s providing an opportunity for design firms like Gensler
Mixed-use neighborhoods, 20-minute cities, and an office you might actually want to work in—these are Gensler’s 2025 predictions for design in 2025.
Uncategorized
Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds
Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables.
Uncategorized
Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says
Men, baby boomers, and postgraduate-degree holders were among those most likely to say they wouldn’t choose medication over dieting.
Uncategorized
The 5 biggest weight loss myths that ‘need to die,’ according to an obesity doctor
If you’ve ever tried to lose weight, you may have experienced one of these popular pitfalls.
Uncategorized
Macron faced with difficult choices after French government falls
President must find a new prime minister who can pass a budget by year’s end
Uncategorized
UK uncovers vast crypto laundering scheme for gangsters and Russian spies
Multibillion-dollar ring across London, Moscow and Dubai connected cash-rich criminals with sanctions evaders
Uncategorized
Crypto advocate Paul Atkins picked as SEC chair by Donald Trump
President-elect also names Gail Slater to run the antitrust unit at the justice department